Concepedia

James W. Smithy

JW

13

Publications

1.1K

Citations

12

H-Index

2014

Active since

Affiliations

Yale University(Current)

Memorial Sloan Kettering Cancer Center

Cornell University

Brigham and Women's Hospital

Parker Institute for Cancer Immunotherapy

James W. Smithy is an author at Yale University specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2014–2024

13

Publications

13

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma

Pok Fai Wong, Wei Wei, James W. Smithy et al. · Clinical Cancer Research · 2019 · 211 citations · Full text

A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1

Patricia Gaule, James W. Smithy, Maria Toki et al. · JAMA Oncology · 2016 · 199 citations

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma

Douglas B. Johnson, Jennifer Bordeaux, Ju Young Kim et al. · Clinical Cancer Research · 2018 · 174 citations

, , +21

High-Plex Predictive Marker Discovery for Melanoma Immunotherapy–Treated Patients Using Digital Spatial Profiling

Maria Toki, Christopher R. B. Merritt, Pok Fai Wong et al. · Clinical Cancer Research · 2019 · 165 citations

Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations

Maria Toki, Nikita Mani, James W. Smithy et al. · Journal of Thoracic Oncology · 2018 · 109 citations · Full text

, , +7

Rows per page

1–5 of 13